CARISMA TherapeuticsCARM

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Mr. Steven Kelly

$56.1M

Market Cap • 24/05/2024

2008

(há 16 anos)
Fundação

2023

(1 year ago)
IPO

NASDAQ

Listagem
Flag of US

Philadelphia

Sede • Pennsylvania

Valuation

Valuation Indicators

Retorno Histórico

CARMSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-5%

1 dia

21/05/2024

-4%

1 semana

17/05/2024

-20%

1 mês

24/04/2024

-74%

1 ano

24/05/2023

-97%

5 anos

24/05/2019

10 anos

Histórico